Background and study aim: During last two decades, there has been a world-wide trend in increasing occurrence of enterococcal infections in the hospitals. The aim of present study was to determine the spectrum of enterococcal infections, species prevalence, antimicrobial resistance and characteristics of vancomycin resistant enterococci (VRE) in a tertiary care hospital, Eastern India. 
Patients and methods:

PATIENTS AND METHODS
Study design and data collection:
A prospective was conducted from July 2013 to June 2014 in the department of clinical microbiology at a tertiary care hospital, Odisha state, Eastern India. A total of 1602 clinical specimens i.e., urine, pus/wound swabs, blood and body fluids were collected from patients and transferred to the laboratory without delay for further processing. Specimens such as throat swabs, sputum and faeces were excluded as enterococci are usually remain as commensals. A detailed evaluation of patient's age, sex, address, associated co-morbidities, admission to the hospital, duration of stay in the hospital and antibiotic treatment history was carried out. An infection is considered as nosocomial if all the elements of a site specific infection criterion of Center of Disease Control and Prevention (CDC) were first present together on or after the 3 rd hospital day (day of hospital admission is day 1) [7].
Sample processing and identification of Enterococcus species:
In the laboratory, all the collected samples were cultured aerobically on solid media i.e., blood agar and MacConkey agar. Blood specimen was cultured in trypticase soy broth (TSB) and subcultured on blood agar, chocolate agar and MacConkey agar. All cultured plates were incubated at 37°C for 48 hours and examined for growth. Identification of genus Enterococcus was done by using colony morphology, Gram All culture media, biochemical reagents, antibiotic discs, vancomycin agar screen test, MIC test strips and standard reference strains used in the study were purchased from Hi Media Laboratories Pvt. Ltd., Mumbai, India.
Genotypic detection of Enterococci and VRE isolates 16S rRNA genes expression for enterococcal isolates:
16S rRNA sequence was amplified from genomic DNA obtained for PCR with the upstream primer: 27F Primer-5'-GAGTTTGATCMTGGCTCAG-3' and the downstream primer: 1492R Primer-5'-GGYTACCTTGTTACGACTT-3',which generated a DNA fragment of approximately 1500 bp. Both of forward and reverse primers were ordered from IDT genomics, Japan.
PCR amplification of 16S rRNA genes:
Total 31DNA isolate mixtures were used in 16S rRNA amplification. PCR was performed in a reaction volume of 25 μL containing 1X Taq polymerase buffer with 1.5 mmol/L -1 of MgCl2 (New England Biolab, USA), 100 μL/mol/L-1 of each dNTP (3B black bio, JAPAN), 0.5 pmol of forward and reverse primers, 50-100 ng of genomic DNA and1.0 U of Taq DNA polymerase (New England biolab, USA). PCR amplifications were performed in a thermal cycler (Biorad, USA). Primers specific to bacterial 16SrRNA were used for PCR amplification. The thermal conditions for 16SrRNA primer pair were [94˚C for predenaturation, 5 min (one cycle); 94˚C for denaturation, 1 min, annealing 55˚C, 1 min, extension 72˚C, 2 min (30cycles);final extension 72˚C, 10 min (one cycle)]. The amplified products were resolved in 1.5% agarose gel, stained with ethidium bromide (10 mg/ml) and photographed under UVP version gel documentation system. Negative and positive controls were included in PCR reactions.
Reproducibility of PCR reactions was checked by performing duplicate reactions for each template DNA isolated. DNA templates used in the study were able to give reproducible PCR amplification results in duplicated experiment. All amplified products were separated by electrophoresis in 1.5% agarose gels with 10 mg/mL-1 of ethidium bromide at 50 V constant voltages for 2 h. The gels were scanned in Gel documentation system (UVP Laboratories, USA) [ Figure 1 ].
Primer designing for vancomycin resistance gene:
One candidate vanA vancomycin resistance gene cluster was evaluated in this study. Resistance genes sequences were collected from the previously submitted NCBI data base (http://www.ncbi.nlm. nih.gov/). All the collected sequences were multiple aligned for online EMBL clastalW data base (http://www.ebi.ac.uk/Tools/msa/clustalw2/). Primers were designed using Primer3 online software (http://primer3.ut.ee/). Forward primer: 5'-GGATAGCTACTCCCGCCTTT-3' and reverse primer: 5'-CCGTTTCCTGTATCCGTCCT-3' were used which generated an amplicon size of approximately 350 bp for vanA gene cluster. The specificity of the primer sets were confirmed by the presence of a single band of appropriate size obtained after PCR amplification. The amplicons were sequenced and submitted to gene bank data base by BLASTN analysis against the vancomycin resistance bacterial genome; the uniqueness of the primers was examined.
PCR amplification for vancomycin resistance gene:
PCR was performed in a total volume of 25 μl containing 10 pmol each of forward and reverse primers, 2.5 mM of MgCl2, 200 μM each of the four deoxyribonucleotide triphosphates (dNTPs), 0.5 U of Taq DNA polymerase, 1x concentration of PCR buffer (Invitrogen, Life Technologies, Brazil) and 50 to 100 ng of isolated bacterial genomic DNA. The template was denatured by heating at pre-denaturation of 95°C for 5 min. This was followed by 39 cycles of denaturation 30 sec at 95°C, 45 sec annealing and 1 min elongation at 72°C, with a final extension of 7 min at 72°C. The Bio-Rad PCR system was used for PCR amplification. The amplicons were resolved in 1.5%agarose gel using 0.5x trisacetate-EDTA (TAE) buffer.
RESULTS
Enterococcal isolates:
Out of 1602 clinical specimens, 961 (60%) were culture positive and 152 (15.8%) non-repeated enterococcal isolates were obtained. E. faecalis was the commonest species 97 (63.8%) isolated, followed by E. faecium 54 (35.5%) and E. casseliflavus 1 (0.7%). Maximum number of Enterococcus species were detected from urine 89 (58.6%), followed by wound and soft tissue discharge 48 (31.6%), blood 9(5.9%) and ascitic fluid 6 (3.9%) [ 
Detection of vancomycin phenotypes and genotypes:
From 20 VRE isolates, 6 had high-level vancomycin resistance (MIC ≥64 µg/ml) and high-level teicoplanin resistant (MIC ≥16 µg/ml) were detected as VanA phenotype and 2 had highlevel vancomycin resistance (MIC ≥32 µg/ml) and teicoplanin sensitive (MIC ≤0.25 µg/ml) were detected as VanB phenotype. All VanA phenotype isolates were positive for vanA gene cluster [ Figure 2 ]. There were few limitations in our study. The Etest for detection of MIC values could be performed only in VRE isolates using vancomycin, teicoplanin and linezolid antibiotic strips. The most common vanA gene cluster could be detected in conventional PCR. The availability and the cost factor were major hindrance for this study.
CONCLUSION
The prevalence of VRE in vancomycin screen agar and KBDDM was 13.2 %. Enterococci were most commonly isolated from ICUs and surgical wards and UTI was the most commonly associated infection. VanA and VanB phenotype were obtained in 40% of VRE isolates and 30% of isolates were associated with vanA gene. More reliable MIC determination test may be performed in all suspected VRE isolates, so that vancomycin resistance phenotypes can be detected and appropriate therapy may be initiated. When-ever feasible PCR should be used for confirmation of VRE genotypes. Thus, a cooperative effort between health care providers and hospital microbiology laboratory personnel is required that will allow VRE to be promptly and accurately detected. Surveillance cultures in high prevalence areas such as ICUs and surgical wards are immediate requirements in order to keep the spread of vancomycin resistance in control.
